These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk. Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Doggen CJ. Br J Haematol; 2010 Apr; 149(1):118-23. PubMed ID: 20096009 [Abstract] [Full Text] [Related]
6. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS). Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briët E, Vandenbroucke JP. Thromb Haemost; 1994 Jun; 71(6):719-22. PubMed ID: 7974338 [Abstract] [Full Text] [Related]
8. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis. Nossent AY, Eikenboom JC, Vos HL, Bakker E, Tanis BC, Doggen CJ, Bertina RM, Rosendaal FR. Thromb Haemost; 2006 Jun; 95(6):942-8. PubMed ID: 16732372 [Abstract] [Full Text] [Related]
9. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Kamphuisen PW, Eikenboom JC, Vos HL, Pablo R, Sturk A, Bertina RM, Rosendaal FR. Thromb Haemost; 1999 May; 81(5):680-3. PubMed ID: 10365736 [Abstract] [Full Text] [Related]
12. High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism. Erkekol FO, Ulu A, Numanoglu N, Akar N. Respirology; 2006 Jan; 11(1):70-4. PubMed ID: 16423204 [Abstract] [Full Text] [Related]
15. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation. Procare-GEHT Group. Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352 [Abstract] [Full Text] [Related]
16. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C. Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [Abstract] [Full Text] [Related]
17. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism. Libourel EJ, Bank I, Meinardi JR, Baljé -Volkers CP, Hamulyak K, Middeldorp S, Koopman MM, van Pampus EC, Prins MH, Büller HR, van der Meer J. Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162 [Abstract] [Full Text] [Related]
19. [High concentration of coagulation factor VIII as a risk factor for thrombosis]. Kamphuisen PW, Eikenboom HC, Rosendaal FR, Bertina RM. Ned Tijdschr Geneeskd; 2001 Nov 17; 145(46):2213-7. PubMed ID: 11757243 [Abstract] [Full Text] [Related]